“…As demonstrated by Ahlström et al in 1995 with 11 Clabeled DOPA (21), 18 F-DOPA has been used in the diagnosis of carcinoids (22)(23)(24), pheochromocytomas (25,26), glomus tumors (27), and pancreatic neuroendocrine tumors (28). Only a few studies have evaluated the value of 18 F-DOPA PET in MTC (7,8,29) and even fewer have used integrated 18 F-DOPA-PET/CT (9,30,31).…”